- Home
- CTMX vs CCIR Comparison
CTMX vs CCIR Comparison
Compare CTMX & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- CCIR
- Stock Information
- Founded
- CTMX 2008
- CCIR 2021
- Country
- CTMX United States
- CCIR United States
- Employees
- CTMX N/A
- CCIR N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- CCIR
- Sector
- CTMX Health Care
- CCIR
- Exchange
- CTMX Nasdaq
- CCIR NYSE
- Market Cap
- CTMX 378.1M
- CCIR 409.5M
- IPO Year
- CTMX 2015
- CCIR 2024
- Fundamental
- Price
- CTMX $2.64
- CCIR $11.36
- Analyst Decision
- CTMX Strong Buy
- CCIR
- Analyst Count
- CTMX 2
- CCIR 0
- Target Price
- CTMX $5.00
- CCIR N/A
- AVG Volume (30 Days)
- CTMX 11.3M
- CCIR 297.3K
- Earning Date
- CTMX 05-12-2025
- CCIR 01-01-0001
- Dividend Yield
- CTMX N/A
- CCIR N/A
- EPS Growth
- CTMX 128.27
- CCIR N/A
- EPS
- CTMX 0.49
- CCIR 0.12
- Revenue
- CTMX $147,557,000.00
- CCIR N/A
- Revenue This Year
- CTMX N/A
- CCIR N/A
- Revenue Next Year
- CTMX N/A
- CCIR N/A
- P/E Ratio
- CTMX $5.44
- CCIR $93.25
- Revenue Growth
- CTMX 23.81
- CCIR N/A
- 52 Week Low
- CTMX $0.40
- CCIR $9.92
- 52 Week High
- CTMX $2.82
- CCIR $13.35
- Technical
- Relative Strength Index (RSI)
- CTMX 67.47
- CCIR N/A
- Support Level
- CTMX $2.35
- CCIR N/A
- Resistance Level
- CTMX $2.75
- CCIR N/A
- Average True Range (ATR)
- CTMX 0.25
- CCIR 0.00
- MACD
- CTMX -0.01
- CCIR 0.00
- Stochastic Oscillator
- CTMX 78.82
- CCIR 0.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.